Dale H Conaway insider trades: Boston Therapeutics (BTHE) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dale reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 15, 2015 | BTHE | ↑ Buy | 5,000 | $0.12 | $600 | Direct | Jun 8, 2015 (24d) |
| Mar 29, 2007 | PRW | ↑ Buy | 400 | $0.75 | $300 | Direct | Apr 2, 2007 (4d) |
| Mar 5, 2007 | PRW | ↑ Buy | 2,000 | $1.08 | $2K | Direct | Mar 8, 2007 (3d) |
| Feb 15, 2007 | PRW | ↑ Buy | 60 | $1.20 | $72 | Direct | Mar 13, 2007 (26d) |
| Feb 15, 2007 | PRW | ↑ Buy | 60 | $1.20 | $72 | Direct | Feb 26, 2007 (11d) |
| Feb 8, 2007 | PRW | ↑ Buy | 7,500 | $0.36 | $3K | Direct | Feb 9, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dale H Conaway's insider trades
Dale H Conaway is a director at Boston Therapeutics (BTHE). Since Feb 8, 2007, Dale has reported 6 open-market purchases worth $6K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTHE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.